(Q61967258)
Statements
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multi-Center, Dose-Titration Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisol®) in Pediatric Subjects With Euvolemic or Hypervolemic Hyponatremia (English)
0 references
February 2012
0 references
January 2014
0 references
4
0 references
2 year
0 references
17 year
0 references